I agree that this site is using cookies. You can find further informations here.
X
Aykan, Musa Baris
53  results:
Search for persons X
?
1

Treatment outcomes and prognostic factors in patients with ..:

Kahraman, Seda ; Karakaya, Serdar ; Kaplan, Muhammed Ali...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Real-World Efficacy and Safety of First-Line Nivolumab Plus..:

Kutlu, Yasin ; Dae, Shute Ailia ; Yilmaz, Feride...
Cancers.  16 (2024)  12 - p. 2251 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Evaluation of the efficacy and safety of nivolumab in the s..:

Karadurmus, Nuri ; Kaplan, Muhammet Ali ; Sendur, Mehmet Ali Nahit...
Current Medical Research and Opinion.  40 (2024)  7 - p. 1171-1178 , 2024
Link: https://doi.org/10.1080/..
 
?
4

The efficacy of palbociclib and ribociclib in the first-lin..:

Yıldırım, Hasan Çağrı ; Kutlu, Yasin ; Mutlu, Emel...
International Journal of Clinical Oncology.  29 (2024)  3 - p. 258-265 , 2024
Link: https://doi.org/10.1007/..
 
?
5

Parents working as health professionals during the pandemic:

Aykan, Emine Bayrak ; Acavut, Gamze ; Aykan, Musa Barış
Journal of Pediatric Nursing.  73 (2023)  - p. e236-e242 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Prognostic factors for regorafenib treatment in patients wi..:

Goktas Aydin, Sabin ; Kavak, Engin Eren ; Topcu, Atakan...
Biomolecules and Biomedicine.  , 2023
Link: https://doi.org/10.17305..
 
?
7

The efficacy of immunotherapy and chemoimmunotherapy in pat..:

Guven, Deniz Can ; Aykan, Musa Baris ; Muglu, Harun...
Cancer Medicine.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
8

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) ..:

Yıldırım, Hasan Çağrı ; Mutlu, Emel ; Chalabiyev, Elvin...
The Breast.  66 (2022)  - p. 85-88 , 2022
Link: https://doi.org/10.1016/..
 
?
9

First-line treatment of patients with HER2-positive metasta..:

Aktürk Esen, Selin ; Ergun, Yakup ; Erol, Cihan...
Bosnian Journal of Basic Medical Sciences.  , 2022
Link: https://doi.org/10.17305..
 
?
10

Treating relapsed and refractory metastatic germ cell tumou..:

Erturk, Ismail ; Karadurmus, Nuri ; Kızıloz, Halil...
Journal of Oncology Pharmacy Practice.  27 (2020)  7 - p. 1657-1664 , 2020
Link: https://doi.org/10.1177/..
 
?
11

Interpretation of blood apelin level across different clini..:

Aykan, Musa Baris ; Tasci, Ilker
Diabetes Research and Clinical Practice.  152 (2019)  - p. 183-184 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Acquired Leukocyte Inclusion Bodies Resembling Döhle Bodies..:

Özgür, Gökhan ; Aykan, Musa Barış ; Yıldırım, Murat...
Turkish Journal of Hematology.  34 (2017)  4 - p. 539-360 , 2017
Link: https://doi.org/10.4274/..
 
?
13

Comment on 'Novel anticoagulants – an update on the latest ..:

Aykan, Musa Baris ; Arslan, Erol ; Demirbas, Seref.
Journal of Oral Pathology & Medicine.  45 (2016)  8 - p. 634-634 , 2016
Link: https://doi.org/10.1111/..
 
?
14

Prognostic factors for regorafenib treatment in patients wi..:

Göktaş Aydın, Sabin ; Kavak, Engin Eren ; Topçu, Atakan...
Biomolecules and Biomedicine.  , 2023
Link: https://hdl.handle.net/2..
 
?
15

The optimal treatment approaches and prognostic factors in ..:

Göktaş Aydın, Sabin ; Çakan Demirel, Burçin ; Bilici, Ahmet...
Acta Oncologica Turcica.  , 2023
Link: https://hdl.handle.net/2..
 
1-15